The Clinical Trial Supply And Logistics Market is expected to increase from USD 5.3 billion in 2025 to USD 7.5 billion in 2030, with a 7.2% CAGR.
In the medical industry, the phase of research that requires a trial of the end product to measure the safety of the drug is known as a clinical trial. Each clinical trial requires distinguished and clean equipment to derive results. Clinical trial and logistic service providers aim to provide support and equipment for clinical trials to the research institute to yield fruitful results. The service providers also manage the trial sites and contact the patients on which the drug can be tested. The prime reason driving the growth of the market is the rising cases of diseases and problems and the need to develop drugs to cure infected patients. Further, robust growth in the industry through the launch of new channels to deliver the services is predicted to open up new opportunities in the market. However, the high initial cost and requirement of a skilled workforce limit the scope of new entrants. The players in the industry who offer similar products face threats and hence are highly competitive.
Rising drug research is projected to increase the demand in the market.
One of the prime reasons supporting the market growth during the forecasted period is the surging investment in drug research and the rise in drug research projects globally. While the initial drug research is funded by the nation’s government, the later stage, precisely, the clinical trial and following stage research is funded by pharmaceutical companies or through a venture capitalist. Increasing complicities of diseases accompanied by rising diseases instance and surging investment in the drug development industry is projected to support the market growth during the forecasted period.
In India, R&D spending by pharmaceutical companies has been increasing significantly. The spending increased from 7% of sales in 2015 to 8.6% of sales in 2019. Furthermore, considerable growth in sales of the Indian pharmaceutical industry is expected to further increase the market.
The lack of substitutes is an advantage for the players in the market.
The vendors in the global clinical trial supply and logistics market are enjoying a significantly high power attributable to the lack of substitutes in the landscape. Although some drug development companies may choose to keep this part of the overall drug research and development process in-house, very low cost-efficiency and very high risks associated with the unavailability of the right supplies in the right quantity and quality where and when required have, for long, kept them at bay. The increasing focus of drug development companies on reducing costs and minimizing risks has nearly driven them out of this market. As a result of the lack of substitutes in the market, the suppliers hold an upper position.
The North American and European clinical trial and logistics supply market is projected to dominate the market.
Based on geography, the global clinical trial and the logistic market are segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific region. It is expected that the North America and Europe clinical trial and the logistic market will dominate the global industry owing to the larger concentration of pharmaceutical research industries. The Asia Pacific market is forecasted to grow at a significant rate.
DHL International GmbH
Marken
Parexel International Corporation
Movianto
Catalent Inc.
| Report Metric | Details |
|---|---|
| Total Market Size in 2025 | USD 5.3 billion |
| Total Market Size in 2030 | USD 7.5 billion |
| Forecast Unit | Billion |
| Growth Rate | 7.26% |
| Study Period | 2020 to 2030 |
| Historical Data | 2020 to 2023 |
| Base Year | 2024 |
| Forecast Period | 2025 – 2030 |
| Segmentation | Service Type, Clinical Phase, Application, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|